Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes. - Araki, E.; Kawamori, R.; Inagaki, N.; Watada, H.; Hayashi, N.; Horie, Y.; Sarashina, A.; Thiemann, S.; Eynatten, M.; Dugi, K.; Woerle, H.‐J. (Diabetes, Obesity & Metabolism, 2013)